ReviewRSC advances2024
Advancements in MAX phase materials: structure, properties, and novel applications.
Review in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Conditional generative models enable targeted exploration of MAX phase design space.Journal of materials chemistry. C · 2026Article
- Elastic Constants and Related Properties of TiMaterials (Basel, Switzerland) · 2026Article
- TiRSC advances · 2026Review
- Manufacturing, Properties, and Applications of Porous TiMaterials (Basel, Switzerland) · 2026Review
- Self-Propagating High-Temperature Synthesis as an Enabling Route for High-Entropy MAX Phases.Materials (Basel, Switzerland) · 2026Review
- Effects of Compositional Ratio of Ti-Al-C on Formation of TiMaterials (Basel, Switzerland) · 2026Article
- Review of Recent Advances in Cold-Sprayed Coatings for Accident-Tolerant Fuel Cladding.Materials (Basel, Switzerland) · 2026Review
- Quantitative Defect-Property Correlations in TiNano-micro letters · 2026Article
- Beyond graphene: the MXene era in bioprinting.Biomedical engineering online · 2026Review
- From MAX to MXene: Unveiling Robust Magnetism and Half-Metallicity in CrNanomaterials (Basel, Switzerland) · 2026Article
- Article
- γ‑Ray, Charged Particle, and Neutron Attenuation Characteristics of Cadmium-Containing 211 MAX Phase Carbides, MACS omega · 2025Article
- Pseudocapacitive Behavior of Blade-Coated MoNanomaterials (Basel, Switzerland) · 2025Article
- Meta-analyses of the evolution of MXene synthesis for bioengineering and artificial intelligence-driven applications.Communications materials · 2025Review
- Two-Dimensional MXenes: Innovative Materials for Efficient Thermal Management and Safety Solutions.Research (Washington, D.C.) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The MAX phase represents a diverse class of nanolaminate materials with intriguing properties that have received incredible global research attention because they bridge the divide separating metals and ceramics. Despite the numerous potential applications of MAX phases, their complex structure leads to a scarcity of readily accessible pure MAX phases. As a result, in-depth research on synthesis methods, characteristics, and structure is frequently needed for appropriate application. This review provides a comprehensive understanding of the recent advancements and growth in MAX phases, focusing on their complex crystal structures, unique mechanical, thermal, electrical, crack healing, corrosion-resistant properties, as well as their synthesis methods and applications. The structure of MAX phases including single metal MAX, i-MAX and o-MAX was discussed. Moreover, recent advancements in understanding MAX phase behaviour under extreme conditions and their potential novel applications across various fields, including high-temperature coatings, energy storage, and electrical and thermal conductors, biomedical, nanocomposites,
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.